D Hilliard

Statistics

Publications

Citations

843

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

D Hilliard is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2005–2010

Publications

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

Gary Herman, C. Melinda Stevens, Koen Vandyck et al. · Clinical Pharmacology & Therapeutics · 2005 · 519 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1

Elizabeth Migoya, Raynald Bergeron, Jutta Miller et al. · Clinical Pharmacology & Therapeutics · 2010 · 177 citations

Life Sciences, Endocrinology, Pharmacology +17

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 100 citations

Life Sciences, Pharmacokinetics, Pharmacology +16

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

Eseng Lai, LA Wenning, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 47 citations

Medicine, Pharmacokinetics, Pharmacology +13

1–4 of 4